Narayana Hrudayalaya Ltd. has informed the Exchange about Investor Presentation
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Narayana Hrudayalaya shared its Q1 FY26 investor presentation with the exchanges. Consolidated revenue grew 15.4% year-on-year to ₹15,073 Mn, with EBITDA at ₹3,607 Mn (23.9% margin) and PAT at ₹1,961 Mn (13.0% margin). The India hospital business posted steady revenue growth, but its EBITDA margin slipped to 20.6% from 21.5% in the previous quarter, even as average revenue per occupied bed rose to ₹17.6 Mn from ₹15.5 Mn a year ago. The company also detailed a capacity expansion pipeline of 1,535 beds across six projects, with combined project cost of around ₹29,740 Mn and completion targeted between FY27 and FY30. Net debt to equity remains low at 0.09, with net borrowings of ₹3,430 Mn.
Solid top-line growth and a clean balance sheet support the stock, but a slight dip in India hospital margins and a heavy multi-year capex pipeline may keep near-term returns muted despite long-term growth visibility.